tallózása szerző szerint "Packer, RJ"

A találatok rendezése: Rendezés: Találatok:

  • Cytogenetic Prognostication Within Medulloblastoma Subgroups 
    Shih, DJ; Northcott, PA; Remke, M; Korshunov, A; Ramaswamy, V; Kool, M; Luu, B; Yao, Y; Wang, X; Dubuc, AM; Garzia, L; Peacock, J; Mack, SC; Wu, X; Rolider, A; Morrissy, AS; Cavalli, FM; Jones, DT; Zitterbart, K; Faria, CC; Schuller, U; Kren, L; Kumabe, T; Tominaga, T; Shin, Ra Y; Garami, Miklós; Hauser, Péter; Chan, JA; Robinson, S; Bognár, László; Klekner, Álmos; Saad, AG; Liau, LM; Albrecht, S; Fontebasso, A; Cinalli, G; De Antonellis, P; Zollo, M; Cooper, MK; Thompson, RC; Bailey, S; Lindsey, JC; Di Rocco, C; Massimi, L; Michiels, EM; Scherer, SW; Phillips, JJ; Gupta, N; Fan, X; Muraszko, KM; Vibhakar, R; Eberhart, CG; Fouladi, M; Lach, B; Jung, S; Wechsler-Reya, RJ; Fevre-Montange, M; Jouvet, A; Jabado, N; Pollack, IF; Weiss, WA; Lee, JY; Cho, BK; Kim, SK; Wang, KC; Leonard, JR; Rubin, JB; de Torres, C; Lavarino, C; Mora, J; Cho, YJD; Tabori, U; Olson, JM; Gajjar, A; Packer, RJ; Rutkowski, S; Pomeroy, SL; French, PJ; Kloosterhof, NK; Kros, JM; Van, Meir EG; Clifford, SC; Bourdeaut, F; Delattre, O; Doz, FF; Hawkins, CE; Malkin, D; Grajkowska, WA; Perek-Polnik, M; Bouffet, E; Rutka, JT; Pfister, SM; Taylor, M (2014)
    PURPOSE: Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group 3, and Group 4. Current medulloblastoma protocols stratify patients based on clinical features: patient age, metastatic stage, extent ...
  • Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis 
    Thompson, EM; Hielscher, T; Bouffet, E; Remke, M; Luu, B; Gururangan, S; McLendon, RE; Bigner, DD; Lipp, ES; Perreault, S; Cho, YJ; Grant, G; Kim, SK; Lee, JY; Rao, AA; Giannini, C; Li, KK; Ng, HK; Yao, Y; Kumabe, T; Tominaga, T; Grajkowska, WA; Perek-Polnik, M; Low, DC; Seow, WT; Chang, KT; Mora, J; Pollack, IF; Hamilton, RL; Leary, S; Moore, AS; Ingram, WJ; Hallahan, AR; Jouvet, A; Fevre-Montange, M; Vasiljevic, A; Faure-Conter, C;; Shofuda, T; Kagawa, N; Hashimoto, N; Jabado, N; Weil, AG; Gayden, T; Wataya, T; Shalaby, T; Grotzer, M; Zitterbart, K; Sterba, J; Kren, L; Hortobágyi, Tibor; Klekner, Álmos; Laszlo, B; Pócza, Tímea; Hauser, Péter; Schuller, U; Jung, S; Jang, WY; French, PJ; Kros, JM; van Veelen, MC; Massimi, L; Leonard, JR; Rubin, JB; Vibhakar, R; Chambless, LB; Cooper, MK; Thompson, RC; Faria, CC; Carvalho, A; Nunes, S; Pimentel, J; Fan, X; Muraszko, KM; Lopez-Aguilar, E; Lyden, D; Garzia, L; Shih, DJ; Kijima, N; Schneider, C; Adamski, J; Northcott, PA; Kool, M; Jones, DT; Chan, JA; Nikolic, A; Garre, ML; Van, Meir EG; Osuka, S; Olson, JJ; Jahangiri, A; Castro, BA; Gupta, N; Weiss, WA; Moxon-Emre, I; Mabbott, DJ; Lassaletta, A; Hawkins, CE; Tabori, U; Drake, J; Kulkarni, A; Dirks, P; Rutka, JT; Korshunov, A; Pfister, SM; Packer, RJ; Ramaswamy, V; Taylor, MD (2016)
    BACKGROUND: Patients with incomplete surgical resection of medulloblastoma are controversially regarded as having a marker of high-risk disease, which leads to patients undergoing aggressive surgical resections, so-called ...